Published in Clin Cancer Res on September 01, 2004
p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol (2010) 3.37
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2009) 2.26
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol (2012) 1.38
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol (2013) 1.17
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck Oncol (2011) 1.13
Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope (2010) 1.10
New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital (2013) 1.07
Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study. Histopathology (2011) 1.03
Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma (2010) 1.03
Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res (2010) 1.02
Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol (2011) 0.98
Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer (2014) 0.98
Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells. Oncogene (2006) 0.97
p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review. Dis Markers (2014) 0.94
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. Br J Cancer (2007) 0.91
The sinonasal tract: another potential "hot spot" for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol (2013) 0.89
Aurora kinases in head and neck cancer. Lancet Oncol (2013) 0.89
Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. Cancer Clin Oncol (2013) 0.87
Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers. Biomed Res Int (2014) 0.84
HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification. Sensors (Basel) (2012) 0.82
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers. Clin Cancer Res (2013) 0.82
Chemoprevention of oral cancer by lyophilized strawberries. Anticancer Res (2013) 0.81
Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol (2015) 0.81
The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (2012) 0.79
Counseling the patient with potentially HPV-related newly diagnosed head and neck cancer. Curr Oncol Rep (2014) 0.78
Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol Diagn Ther (2012) 0.78
Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Patholog Res Int (2011) 0.77
Identifying the risk factors for late-stage head and neck cancer. Expert Rev Anticancer Ther (2011) 0.77
Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers. Br J Cancer (2015) 0.75
Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget (2016) 0.75
ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines. Oncotarget (2016) 0.75
Is biomarker research advancing in the era of personalized medicine for head and neck cancer? Int J Clin Oncol (2014) 0.75
Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain. Eur Arch Otorhinolaryngol (2016) 0.75
Saturated molecular map of the rice genome based on an interspecific backcross population. Genetics (1994) 6.22
Construction of coliphage lambda Charon vectors with BamHI cloning sites. Gene (1980) 5.83
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature (1994) 5.73
Validation of tissue microarray technology in breast carcinoma. Lab Invest (2000) 5.50
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet (2001) 3.52
The ease of DNA unwinding as a determinant of initiation at yeast replication origins. Cell (1988) 2.95
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol (1999) 2.79
Transposon diversity in Arabidopsis thaliana. Proc Natl Acad Sci U S A (2000) 2.57
Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res (1995) 2.47
HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem (2000) 2.29
Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci U S A (1999) 2.27
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. Leukemia (2009) 2.25
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer (2000) 2.20
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther (2014) 2.11
A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature (1997) 2.03
New beginnings in studies of eukaryotic DNA replication origins. Biochim Biophys Acta (1989) 2.00
BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer. J Clin Oncol (2001) 1.97
Ease of DNA unwinding is a conserved property of yeast replication origins. Nucleic Acids Res (1993) 1.95
Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther (2008) 1.94
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol (1995) 1.94
DNA helical stability accounts for mutational defects in a yeast replication origin. Proc Natl Acad Sci U S A (1992) 1.93
Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol (1995) 1.93
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer (1999) 1.89
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res (1999) 1.86
Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer (2001) 1.83
Factors affecting the pullout strength of cancellous bone screws. J Biomech Eng (1996) 1.77
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76
Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer (1998) 1.75
Impact of acid and pepsin on human esophageal prostaglandins. Am J Gastroenterol (1994) 1.75
Vinculin is associated with the E-cadherin adhesion complex. J Biol Chem (1997) 1.73
Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene (2006) 1.73
Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem (2000) 1.70
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Purification, cloning, and characterization of the CEL I nuclease. Biochemistry (2000) 1.68
Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill (2013) 1.68
Activation of silent replication origins at autonomously replicating sequence elements near the HML locus in budding yeast. Mol Cell Biol (1999) 1.68
Gastric metastases originating from breast cancer: report of 8 cases and review of the literature. Anticancer Res (2009) 1.68
A DNA unwinding element and an ARS consensus comprise a replication origin within a yeast chromosome. EMBO J (1993) 1.67
Granulosa cell tumor of the ovary. Cancer Treat Rev (2007) 1.63
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci (1998) 1.63
Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol (1999) 1.63
True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys (2000) 1.62
Mung bean nuclease I. Terminally directed hydrolysis of native DNA. Biochemistry (1976) 1.57
Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients. Br J Anaesth (2011) 1.56
Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol (1998) 1.55
Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol (1997) 1.54
Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol (2000) 1.54
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am (2006) 1.50
Breast-conserving therapy in the setting of collagen vascular disease. Cancer J (2001) 1.50
Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res (2001) 1.50
Mung bean nuclease I. Physical, chemical, and catalytic properties. Biochemistry (1976) 1.47
Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ (1999) 1.46
Altered DNA conformations detected by mung bean nuclease occur in promoter and terminator regions of supercoiled pBR322 DNA. Nucleic Acids Res (1985) 1.46
Multiple DNA elements in ARS305 determine replication origin activity in a yeast chromosome. Nucleic Acids Res (1996) 1.46
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res (1998) 1.44
Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med (2011) 1.43
Characteristics and surgical management of respiratory complications accompanying pathologic lesions of the brain stem. Ann Surg (1980) 1.43
Dynamic interaction of PTPmu with multiple cadherins in vivo. J Cell Biol (1998) 1.42
Thermal energy suppresses mutational defects in DNA unwinding at a yeast replication origin. Proc Natl Acad Sci U S A (1990) 1.40
'Locked-in syndrome' for 27 years following a viral illness: clinical and pathologic findings. Neurology (1991) 1.39
Nonconditional logistic regression analysis of risk factors in rheumatic heart disease. Int J Cardiol (1992) 1.39
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med (2000) 1.39
Yeast regulatory sequences preferentially adopt a non-B conformation in supercoiled DNA. Nucleic Acids Res (1987) 1.38
Alpha-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with beta-catenin. J Biol Chem (1997) 1.37
Changes in site specificity of single-strand-specific endonucleases on supercoiled PM2 DNA with temperature and ionic environment. Nucleic Acids Res (1984) 1.32
Action of mung bean nuclease on supercoiled PM2 DNA. J Biol Chem (1982) 1.30
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol (2001) 1.28
alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo. J Biol Chem (2000) 1.27
Functional equivalency and diversity of cis-acting elements among yeast replication origins. Mol Cell Biol (1997) 1.26
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol (1997) 1.25
Gene-sized pieces produced by digestion of linear duplex DNA with mung bean nuclease. Biochemistry (1978) 1.25
PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. J Cell Sci (1999) 1.22
Bacterial census of poultry intestinal microbiome. Poult Sci (2013) 1.19
Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol (2000) 1.19
cis-acting components in the replication origin from ribosomal DNA of Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.18
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br J Cancer (2009) 1.18
Characterization of alpha-actinin from Acanthamoeba. Cell Motil Cytoskeleton (1986) 1.17
Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ (1997) 1.16
Radiobiological effects of a low-energy ion beam on wheat. Radiat Environ Biophys (2001) 1.16
Mung bean nuclease cleavage of a dA + dT-rich sequence or an inverted repeat sequence in supercoiled PM2 DNA depends on ionic environment. Nucleic Acids Res (1984) 1.15
Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia (2009) 1.15
Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. Cancer J Sci Am (1998) 1.15
The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene (2007) 1.14
The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J Immunol (2001) 1.13
Computed tomography of temporal bone pneumatization: 1. Normal pattern and morphology. AJR Am J Roentgenol (1985) 1.13
The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol (1998) 1.12
Association of enzymes with replicating and nonreplicating simian virus 40 chromosomes. Cold Spring Harb Symp Quant Biol (1979) 1.11
Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network. IET Syst Biol (2007) 1.11
A long-term study of 370 autotransplanted premolars. Part III. Periodontal healing subsequent to transplantation. Eur J Orthod (1990) 1.11
HSP90 as a marker of progression in melanoma. Ann Oncol (2007) 1.11
DNA replication forks pause at silent origins near the HML locus in budding yeast. Mol Cell Biol (2001) 1.11
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol (2004) 1.10
Mitochondria-dependent signalling pathway are involved in the early process of radiation-induced bystander effects. Br J Cancer (2008) 1.09
Constitutive nitric oxide acting as a possible intercellular signaling molecule in the initiation of radiation-induced DNA double strand breaks in non-irradiated bystander cells. Oncogene (2006) 1.08
Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant (2008) 1.07
Elaboration of an electroporation protocol for large plasmids and wild-type strains of Bacillus thuringiensis. J Appl Microbiol (2009) 1.07